Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended … Continue reading News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),